Bionet Cash Flow Reinvestment Rate
Bionet cash flow reinvestment rate. Bionet (1784) has a Cash Flow Reinvestment Rate of 1.19x as of June 2026, reinvesting NT$60.75 Million (capex NT$10.14 Million plus investments NT$-50.60 Million) from operating cash flow of NT$51.22 Million. Explore cash flow to debt ratio of Bionet to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Bionet (2019–2025)
Cash flow reinvestment rate of Bionet from 2019 to 2025. Historical reinvestment intensity for Bionet across 7 annual periods. Explore 1784 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Bionet Cash Flow Reinvestment Rate by Year (2019–2025)
Bionet cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Bionet. For the full cash flow conversion analysis, see Bionet (1784) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.04x | NT$302.51 Million | NT$148.04 Million | NT$132.18 Million | ▼ -53.3% |
| 2024 | 4.38x | NT$772.28 Million | NT$176.49 Million | NT$103.49 Million | ▲ +53.6% |
| 2023 | 2.85x | NT$436.21 Million | NT$153.09 Million | NT$26.28 Million | ▲ +653.0% |
| 2022 | 0.38x | NT$35.82 Million | NT$94.65 Million | NT$32.91 Million | ▼ -82.4% |
| 2021 | 2.15x | NT$29.80 Million | NT$13.88 Million | NT$16.66 Million | ▲ +101.9% |
| 2020 | 1.06x | NT$78.35 Million | NT$73.66 Million | NT$38.03 Million | ▼ -95.0% |
| 2019 | 21.27x | NT$56.78 Million | NT$2.67 Million | NT$11.60 Million | — |